江西永芳科技有限公司

Jiangxi Yongfang Technology Co., Ltd.

Main pharmaceutical intermediates

4000 tons/year chlorobenzoic acid, 6000 tons/year benzonitrile series products

NEWS

The pollution problem of pharmaceutical intermediate companies is outstanding, and all departments need to work together

Time: 2021-01-05

[Editor's Viewpoint of China Pharmaceutical Network] In accordance with the unified deployment of the Ministry of Environmental Protection, on February 15th, the special supervision of air quality in the first quarter of 2017, 18 supervision teams have all been stationed in 18 cities in Beijing-Tianjin-Hebei and surrounding areas. At present, the main problems discovered by the special inspection team of the Ministry of Environmental Protection include the inadequate pressure transmission in Shijiazhuang City, the county-level government is still dominated by the environmental protection bureau in implementing the emergency plan for heavy pollution weather, and the participation of other departments is not high. The pollution of small and medium-sized enterprises producing pharmaceutical intermediates in Shijiazhuang City is relatively serious.

Disorderly competition in the industry is becoming increasingly fierce

The so-called pharmaceutical intermediates are actually some chemical raw materials or chemical products used in the process of drug synthesis. This kind of chemical product does not require a pharmaceutical production license and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of pharmaceuticals.

It is understood that after years of development, the chemical raw materials and intermediates required for my country's pharmaceutical production can basically be matched, and only a small part of it needs to be imported. Moreover, due to my country's abundant resources and low raw material prices, many intermediates have been exported in large quantities.

Looking at the entire industry, most of my country’s pharmaceutical intermediate manufacturers are currently private enterprises with flexible operations and small investment scale. As the country pays more and more attention to environmental protection issues, the pressure on manufacturers to build environmental protection treatment facilities has increased, which has forced companies to Only by continuously developing new products or continuously improving the production process can we maintain a higher production profit.

Moreover, since the production profit of pharmaceutical intermediates is higher than that of chemical products, and the production processes of the two are basically the same, more and more small chemical companies have joined the ranks of producing pharmaceutical intermediates, resulting in increasingly disorderly competition in the industry. fierce. In the face of profit, many manufacturers bury "green", which has also caused a lot of industrial pollution.

In front of environmental protection pressure

All departments need to work together

According to Xue Xinli, director of the Tianjin Development and Reform Commission, continuous strengthening of air pollution control cooperation between the three places, unified implementation of regional heavy-polluted weather warning standards, strengthening of environmental law enforcement and emergency response linkage, joint environmental law enforcement supervision and inspection, and coordinated investigation and punishment of cross-border environmental violations will be Current goals.

Relevant departments should fully cooperate with the progress of pollution control. Small and medium-sized pharmaceutical intermediates, as a part of the pollution source, must also fully cooperate with environmental law enforcement agencies to pay attention to pollution problems, put down immediate interests and take the path of sustainable development.

The pharmaceutical industry is not only a high-risk, high-investment, high-tech, and high-return industry, but also an industry with heavy environmental protection, energy conservation, and emission reduction tasks in my country. Since the beginning of the 21st century, my country's pharmaceutical industry has maintained a relatively rapid development speed. In the face of environmental protection pressure, what pharmaceutical companies need is to upgrade environmental protection technology and follow the concept of green production, rather than blindly engage in production and evade environmental protection principles.

Summary:

Generally speaking, the task of pollution control in our country is still very arduous. Small, scattered and polluting enterprises exist to varying degrees, and the difficult "hard bones" will not be reduced. At the same time, it should be noted that the pollution problem does not form in a short period of time, and it cannot be solved overnight and overnight. It requires a relatively long process. Judging from the current situation, all departments in our country must work together to be solid, step by step, and long-term success. As long as we continue to promote air pollution prevention and control work, one day we will get out of the "smoggy sky."

(Source: China Pharmaceutical Network)

HOME  |   ABOUT US  |   PRODUCTS  |   NEWS  |   FACTORY  |   HONORS  |   ORDER  |   CONTACT  |   中文版

Copyright(C)2021, Jiangxi Yongfang Technology Co., Ltd. All Rights Reserved. Supported by ChinaChemNet ChemNet Toocle Copyright Notice 备案序号:苏ICP备11031516号